GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (LSE:OVB) » Definitions » Preferred Dividends

Ovoca Bio (LSE:OVB) Preferred Dividends : £0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Ovoca Bio Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Ovoca Bio's preferred dividends for the six months ended in Jun. 2024 was £0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Jun. 2024 was £0.00 Mil.


Ovoca Bio Preferred Dividends Historical Data

The historical data trend for Ovoca Bio's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovoca Bio Preferred Dividends Chart

Ovoca Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Preferred Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ovoca Bio Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ovoca Bio Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.


Ovoca Bio  (LSE:OVB) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ovoca Bio Business Description

Traded in Other Exchanges
Address
17 Pembroke Street Upper, Dublin, IRL, D02 AT22
Ovoca Bio PLC is a life science investment company. The company is engaged in investing in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. The group has two business segments, bio-pharmaceutical and investment, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX - Libicore - a novel synthetic peptide, administrated through a nasal spray.

Ovoca Bio Headlines

From GuruFocus

Overlay Shares Core Bond ETF Crosses $100 Million in Assets

By PRNewswire PRNewswire 07-09-2020

Overlay Shares Cross $500 Million in Assets

By PRNewswire PRNewswire 02-01-2022

Overlay Shares Launch New ETFs and Cross $300 Million in Assets

By PRNewswire PRNewswire 01-21-2021

Overlay Shares Reach 5-Year Track Record

By PRNewswire 10-03-2024

Top 5 2nd Quarter Trades of Advocacy Wealth Management Services, LLC

By GuruFocus Research GuruFocus Editor 07-06-2022